Market Overview:
The global Sandostatin LAR drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of tumors and other diseases, rising demand for better treatment options, and growing awareness about available treatments. By type, the market is segmented into 500mcg, 1000mcg, and other types. The 1000mcg type segment is expected to grow at a higher CAGR than the 500mcg type segment during the forecast period. By application, the market is divided into tumors, bleeding esophageal varices (BEV), and other applications. The tumors application segment accounts for a major share of this market owing to increasing incidence of cancer across the globe.
Product Definition:
Sandostatin LAR is a long-acting form of the drug sandostatin. It is used to treat symptoms of carcinoid tumors, including diarrhea, flushing, and shortness of breath.
500mcg:
500MCG is a prescription medicine used for the treatment of Sandostatin LAR. It's main action is to reduce elevated levels of lysosomal acid in patients with multiple system atrophy (MSA), however, it has other effects such as improvement in breathing and increase in the strength and mobility of muscles. 500MCG injections are also used for treating diseases such as muscular dystrophy, myasthenia gravis and post-polio syndrome among others.
1000mcg:
1000MCG is the highest dosage of Sandostatin LAR (Larazotide) that can be given to a patient. It is used in the treatment of diabetic foot ulcers, venous leg ulcers and pressure wounds. 1000 MCG contains 1 mg/mL solution of larazotide in water for injection.
Application Insights:
The other application segment includes the treatment of chronic kidney failure, pulmonary hypertension and heart failure. The growing prevalence of these conditions is anticipated to drive the demand for sandostatin LAR drugs over the forecast period. For instance, as per estimates by U.S. National Library of Medicine National Institutes of Health in 2017, around 60 million people are suffering from chronic kidney disease across globe which is expected to increase with aging and result in dialysis or a kidney transplantation procedure eventually leading to death due to lack of kidneys. This condition also leads to high blood pressure which further increases mortality rate making it one of the major causes for deaths globally along with cancer and cardiovascular diseases among others thus driving market growth during future years.
Regional Analysis:
North America dominated the global sandostatin LAR market in 2017. The presence of key players, favorable reimbursement scenario and high adoption rate for novel drugs are some of the factors responsible for its large share. In addition, increasing R&D activities by various companies is expected to fuel growth over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising incidences of cancer and other diseases coupled with growing healthcare expenditure in emerging economies such as India & China & South Korea among others. Moreover, increasing awareness about available treatment options will also boost regional market growth during the estimated time span from 2018 to 2030 (see Figure 1).
Key companies involved in this space include: Pfizer Inc.; Johnson & Johnson Services, Inc.
Growth Factors:
- Increasing incidence of neuroendocrine tumors (NETs)
- Growing demand for better quality of life in patients with NETs
- Increasing awareness about Sandostatin LAR Drugs among physicians and patients
- Launch of new products by key players
- Expansion of distribution network
Scope Of The Report
Report Attributes
Report Details
Report Title
Sandostatin LAR Drugs Market Research Report
By Type
500mcg, 1000mcg, Other
By Application
Tumors, Bleeding Esophageal Varices, Other
By Companies
Novartis, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Sandostatin LAR Drugs Market Report Segments:
The global Sandostatin LAR Drugs market is segmented on the basis of:
Types
500mcg, 1000mcg, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tumors, Bleeding Esophageal Varices, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Novartis
Highlights of The Sandostatin LAR Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 500mcg
- 1000mcg
- Other
- By Application:
- Tumors
- Bleeding Esophageal Varices
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sandostatin LAR Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sandostatin LAR is a drug that belongs to the class of medications called statins. Statins are drugs that help lower cholesterol levels in the blood. Sandostatin LAR is used to treat heart disease and other conditions caused by high cholesterol levels.
Some of the key players operating in the sandostatin lar drugs market are Novartis, Novartis.
The sandostatin lar drugs market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sandostatin LAR Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sandostatin LAR Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sandostatin LAR Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sandostatin LAR Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sandostatin LAR Drugs Market Size & Forecast, 2020-2028
4.5.1 Sandostatin LAR Drugs Market Size and Y-o-Y Growth
4.5.2 Sandostatin LAR Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 500mcg
5.2.2 1000mcg
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Tumors
6.2.2 Bleeding Esophageal Varices
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sandostatin LAR Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sandostatin LAR Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 500mcg
9.6.2 1000mcg
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Tumors
9.10.2 Bleeding Esophageal Varices
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 500mcg
10.6.2 1000mcg
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Tumors
10.10.2 Bleeding Esophageal Varices
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 500mcg
11.6.2 1000mcg
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Tumors
11.10.2 Bleeding Esophageal Varices
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 500mcg
12.6.2 1000mcg
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Tumors
12.10.2 Bleeding Esophageal Varices
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 500mcg
13.6.2 1000mcg
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Tumors
13.10.2 Bleeding Esophageal Varices
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sandostatin LAR Drugs Market: Competitive Dashboard
14.2 Global Sandostatin LAR Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Novartis
